The Epigenetic Effects of Prenatal Cadmium Exposure by unknown
EARLY LIFE ENVIRONMENTAL HEALTH (J SUNYER, SECTION EDITOR)
The Epigenetic Effects of Prenatal Cadmium Exposure
Nadia Vilahur1 & Marie Vahter1 & Karin Broberg1
Published online: 8 April 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Prenatal exposure to the highly toxic and common
pollutant cadmium has been associatedwith adverse effects on
child health and development. However, the underlying bio-
logical mechanisms of cadmium toxicity remain partially un-
solved. Epigenetic disruption due to early cadmium exposure
has gained attention as a plausible mode of action, since epi-
genetic signatures respond to environmental stimuli and the
fetus undergoes drastic epigenomic rearrangements during
embryogenesis. In the current review, we provide a critical
examination of the literature addressing prenatal cadmium ex-
posure and epigenetic effects in human, animal, and in vitro
studies. We conducted a PubMed search and obtained eight
recent studies addressing this topic, focusing almost exclu-
sively on DNA methylation. These studies provide evidence
that cadmium alters epigenetic signatures in the DNA of the
placenta and of the newborns, and some studies indicated
marked sexual differences for cadmium-related DNA methyl-
ation changes. Associations between early cadmium exposure
and DNAmethylation might reflect interference with de novo
DNA methyltransferases. More studies, especially those in-
cluding environmentally relevant doses, are needed to confirm
the toxicoepigenomic effects of prenatal cadmium exposure
and how that relates to the observed health effects of cadmium
in childhood and later life.
Keywords Cadmium . DNAmethylation . DNA
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Introduction
Exposure to Cadmium
Cadmium is ubiquitous in the environment. Exposure to the
general population occurs mainly not only via intake of plant-
derived foods and certain types of seafood but also through
tobacco smoking and industrial emissions [1]. In general,
women have higher internal levels of cadmium than men,
likely as a result of higher gastrointestinal absorption of cad-
mium in women with low iron stores or due to genetic factors
[2–5]. Further, pregnant women appear to accumulate more
cadmium than nonpregnant women [4].
Unlike arsenic, lead, and methylmercury, which effectively
cross the placental barrier in humans and other mammals lead-
ing to direct fetal exposure [6], cadmium is largely retained in
the placenta, where it can accumulate to high concentrations
[7, 8, 9••].
Cadmium Toxicity During Critical Developmental
Periods
Cadmium is a highly toxic metal ranked among the top five on
the 2011 Agency for Toxic Substances and Disease Registry
(ATDSR) Priority List of Hazardous Substances [10]. Numer-
ous studies in adults have reported that cadmium exposure has
adverse effects on the kidney and bone; more recently, low-
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dose cadmium intake has been associated with the risk of
developing cardiovascular disease and some types of cancer
[1, 11–13]. There is increasing evidence that cadmium can
also be toxic early in life, with effects that may persist over
time. Epidemiological studies have reported associations be-
tween prenatal cadmium exposure, measured through concen-
trations in maternal urine or cord blood, and negative effects
on anthropometric outcomes in newborns and children at 3–
5 years of age, with some studies pointing towards stronger
associations in girls compared to boys [14, 15••, 16–18].
Moreover, increased concentrations of cadmium have been
found in placentas from mothers delivering low birth weight
neonates [19]. There is some evidence indicating that prenatal
exposure to cadmium may affect the immune system from a
very early age, expressed as a higher risk of atopic dermatitis
in 6-month-old infants [20]. Mice prenatally exposed to envi-
ronmentally relevant doses of cadmium showed postnatal al-
terations in immune cell development and function [21].
Cadmium can act as an endocrine disrupting chemical,
since it has been shown to interfere with progesterone, testos-
terone, and leptin synthesis and to alter the thyroid hormone
system [22–25]. Mice and rats prenatally exposed to cadmium
showed impairments of their reproductive systems, both in
males and in females [26, 27].
The mechanisms of early life toxicity of cadmium are not
yet clear. Cadmium exposure during pregnancy, leading to
accumulation in the placenta, seems to disturb zinc transfer
to the fetus, interfere with glucocorticoid balance, and affect
the regulation of insulin growth factor-related proteins; and it
has also been shown to inhibit the migration of human pla-
cental trophoblast cells [24, 28, 29, 30••, 31, 32]. Additionally,
low-level exposure to cadmium has been associated with in-
creased oxidative stress in early life [33]. A possible underly-
ing molecular mechanism for the prenatal action of cadmium
is through interference with the epigenetic machinery.
Early Environmental Exposures and Epigenetics
In the last decade, epigenetic processes have gained attention as
potential mediators of the adverse health effects observed in
relation to exposure to environmental toxicants, an expanding
area of research known as toxicoepigenomics [34–36]. Epige-
netic marks, broadly defined as dynamic changes to the ge-
nome other than changes in the DNA sequence itself, can affect
the regulation of gene expression and can be transmitted
through mitosis and/or possibly through meiosis [37]. These
epigenetic marks include methylation on the cytosine residues
of DNA (when the cytosine is followed by a guanine, a CpG
site), posttranslational modifications of histone proteins, and
small noncoding RNA molecules (so-called microRNAs) that
may interfere with gene transcription and/or translation
[38–41]. Epigenetic mechanisms have key functions in regulat-
ing cellular homeostasis, lineage-specific gene expression, and
establishment of developmental programs, which may have
long-lasting influence on future health. During human embry-
onic development, a series of epigenetic changes take place at
the zygote stage and during formation of primordial germ cells;
these changes involve two main waves of genome-wide
epigenomic reprogramming leading to the sequential activation
and repression of genes important for the control of growth and
metabolism [42–44]. In addition, sex-specific differences in
epigenetic marks are generated early after fertilization [45].
This window of epigenetic developmental plasticity in
humans, from preconception to early childhood, represents a
period of enhanced vulnerability to environmental stimuli that
can lead to aberrant gene expression, enhance the risk of dis-
ease in early life, and program individuals for risks of disease
in adult life [46]. Indeed, epigenetic effects early in life have
been found for prenatal toxic exposures such as arsenic and
tobacco smoke [47–49].
The aim of the present review was to summarize the current
state of knowledge and provide a critical examination of report-
ed epigenetic changes caused by in utero exposure to cadmium.
To that end, we have selected and summarized original research
articles that have addressed this topic in epidemiological, ani-
mal, and in vitro studies conducted on relevant cell types.
Methods
Sources of Information and Search Strategy
We conducted a bibliographic search using the electronic data
source PubMed (National Library of Medicine, Bethesda, MD,
USA: http://www.ncbi.nlm.nih.gov/pubmed), and included in
this review all published articles in English within a time frame
of 10 years (31st December 2004 to 31st December 2014) that
reported any epigenetic data measured either in blood or in
other tissues in relation to prenatal exposure to cadmium in
humans or animal models. In addition, we also included
in vitro studies on specific cell types relevant to prenatal
exposure, such as embryonic stem cells, fetal-derived cells, or
placental trophoblasts. The references of the selected articles
were also used as an additional source of relevant studies.
The following key terms and their combinations were used
in the literature search: Bcadmium^, Bprenatal^, Bpregnancy ,^
Bmaternal^, Bepigenetic^, Bmethylation^, Bhistone^,
BmicroRNA^, Bin utero^, and Bmetal*^.
Results
Literature Review
A total of eight original research articles were identified ac-
cording to our search criteria. Among them, three were human
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cohort studies, two were conducted in animals, and three were
in vitro. The characteristics and main results of these studies
are summarized in Tables 1, 2, and 3.
Human Studies
Three recent epidemiologic studies explored the association
between prenatal cadmium exposure and DNAmethylation in
blood cells (Table 1). One study measured global DNA meth-
ylation using as a proxy the methylation of the human long
interspersed nuclear element 1 (LINE-1), a transposable repet-
itive sequence that constitutes approximately 17 % of the hu-
man genome [50]. LINE-1 is typically highly methylated in
normal tissues, whereas hypomethylation of LINE-1 is com-
monly observed in cancerous tissues and is believed to cause
alterations in gene expression and chromatin packaging, as
well as increasing genomic instability [51–53]. Here,
periconceptional cadmium intake, estimated from food fre-
quency questionnaires (expressed per increase in one standard
deviation or ∼4 μg Cd/day), was significantly associated with
LINE-1 hypomethylation in cord blood DNA (n=557 new-
borns) in fully adjusted models including methyl donors (vi-
tamin B12, betaine, choline, and folate), child’s sex, maternal
age, race, smoking, gestational weight gain, and education as
covariates [50]. Cadmium-related hypomethylation of LINE-
1 could increase its transposase activity, which may induce
genomic alterations that could be associated with adverse
chronic health outcomes later in life [54, 55]. In the same
study, the authors also found that the estimated cadmium in-
take was associated with LINE-1 DNA hypermethylation in
maternal blood in the first trimester of pregnancy, a finding
that is in contrast to a study in adult nonpregnant and non-
smoking Andean women in Argentina, where low-level cad-
mium exposure was associated with LINE-1 hypomethylation
in peripheral blood DNA [56].
The two other studies measured genome-wide DNA meth-
ylation using commercial DNAmethylation arrays that screen
a large number of individual CpG sites throughout the ge-
nome. The first is a cohort study based on 127 mother-child
pairs from a rural area of Bangladesh. All participant mothers
were nonsmokers, and cadmium exposure, mostly derived
from food consumption, was based on measured concentra-
tions in maternal blood collected in early pregnancy around
week 14 (median 1.3, range 0.38–5.4μg/kg) [57]. DNAmeth-
ylation was assessed in cord blood using the Illumina
HumanMethylation450K array, whichmeasures approximate-
ly 450,000 CpG sites. No significant associations of cadmium
and DNA methylation were found after adjustments for mul-
tiple testing. However, a marked sex dimorphism in cadmium-
related methylation changes was observed, which seemed to
be more pronounced in boys: 96 % of the top 500 CpGs in
boys showed hypermethylation in relation to increasing cad-
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were hypermethylated in girls. Neither verification nor valida-
tion of the top cadmium-associated CpG sites using another
technique, e.g., bisulfite pyrosequencing was conducted in
this study. Pathway analysis, where cadmium-related CpGs
are annotated to biological function, showed some overlap-
ping pathways for both sexes; and moreover, cell death-
related genes were enriched in boys, whereas embryonic and
organ development-related genes were enriched in girls. Fi-
nally, among the 500 top CpGs positively correlated with
cadmium, four (three in girls and one in boys) were also as-
sociated with lower birth weight in covariate-adjusted models
(although associations did not reach significance after
multiple-testing correction), thus suggesting that DNA meth-
ylation may be involved in the cadmium-related impairment
of fetal growth.
The second study examined 17 mother-child pairs and was
nested in a larger study of a population from the USA. Cad-
mium concentrations were measured in blood collected at de-
livery, and maternal-newborn pairs were divided into two ex-
posure categories (high or low) based on maternal blood cad-
mium 50th percentile for pregnant women (0.2 μg/L) accord-
ing to the National Health and Nutrition Examination Survey
(NHANES) [58]. DNA methylation was measured using the
Methylated CpG island recovery assay (MIRA) followed by
hybridization to the Affymetrix Human Promoter 1.0R arrays
(Affymetrix), which assesses over 4.6 million sites located in
human gene promoter regions. Non-overlapping gene sets
were found in maternal (n=92 genes) and in fetal (n=61)
blood DNA that were differentially methylated (defined as
an average island promoter methylation with a minimum ab-
solute change of 30 %; and a P value <0.05 measured by
ANOVA) in relation to prenatal cadmium exposure, and these
were always hypermethylated, although they were not statis-
tically significant after false discovery rate adjustment. Simi-
larities at the biological pathway level were identified between
the two groups of genes (maternal vs. fetal) with an enrich-
ment of genes that play a role in transcriptional regulation and
apoptosis. The same study evaluated DNA methylation
changes in relation to cotinine, a primary biomarker of nico-
tine exposure, measured in maternal serum and dichotomized
as presence or absence according to the detection limit. A total
of 366 cotinine-associated differentially methylated genes
were found in fetal DNA, and there was an overlap of 30
genes between the cadmium and the cotinine-associated gene
sets, which were hypermethylated in relation to both expo-
sures. Finally, the methylation degree of the apoptosis-
related gene PRR13, identified as differentially methylated
only in fetal DNA in relation to cadmium using the MIRA
assay, was verified in DNA of 15 newborns by methylation-
specific quantitative polymerase chain reaction, and both tech-
niques were found to be in relatively good agreement
(Spearman’s rank correlation r=0.53, P<0.05). No validation
of results was conducted in additional samples.
The findings of the two genome-wide studies are difficult
to compare, mainly because of differences in study design
including exposure assessment timing (first trimester vs deliv-
ery), genome-wide coverage of CpG sites and sample size,
which was too small in the study by Sanders and collaborators
to stratify by sex. Notably, both studies showed changes in
methylation in genes related to cell death with more cadmium
exposure; effects on these genes could be linked to different
health effects of cadmium, including cancer [59, 60]. Finally,
none of the studies conducted in cord blood DNAwere able to
perform cell sorting or conducted statistical adjustments for
cell composition estimated using methods such as the House-
man, recently adapted as well for tissues for which reference
datasets are unavailable [61]; and this might represent a source
of unmeasured confounding and, more importantly,
underpower the estimation of cadmium-induced epigenetic
effects.
Animal Studies
Different tissues, including term placenta, cord blood, and
saliva in newborns have unique epigenetic signatures, both
globally and in specific loci [62]. Animal studies therefore
represent a valuable tool to study epigenetic effects of expo-
sure to toxic chemicals during pregnancy on organs that oth-
erwise would remain difficult to explore in humans, especially
in newborns and children.
In a study performed on chick embryos, where a single
dose of 50 μL of 50 μM (5.620 μg/L) cadmium (i.e.,
0.281 ng of cadmium) was administered and compared to
control embryos administered with saline only, decreased
global DNA methylation was reported during very early em-
bryogenesis 64 h after fertilization (4-h post-cadmium treat-
ment), measured in situ in whole embryos using immunohis-
tochemical staining with a monoclonal antibody against 5-
methylcytidine. These changes in DNA methylation were ac-
companied by lower levels of expression of the de novo meth-
yltransferases DNMT3A and DNMT3B at this specific stage
[63]. None of these effects were observed for cadmium expo-
sure at 68 h after fertilization (8-h post-cadmium treatment).
The authors suggested that the epigenetic changes early in
embryogenesis could be related to defects in abdominal wall
development in the chick embryos as a result of cadmium
exposure, previously reported by the same laboratory [64].
Another study evaluated the effect of cadmium exposure
through drinking water at 50 ppm (50.000 μg/L) administered
ad libitum to rats during the whole pregnancy on DNA meth-
ylation of the glucocorticoid receptor in the liver of the off-
spring, measured by bisulfite pyrosequencing [65]. Here, male
and female offspring (n=6 in each group) were analyzed sep-
arately at the end of pregnancy (day 20), and opposite effects
were observed between the sexes in relation to this high level
of cadmium exposure (estimated 5 ng per 100 mL of drinking
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water): males showed glucocorticoid receptor hypermethyla-
tion accompanied by lower gene expression, while females
showed hypomethylation and overexpression of the gene,
when compared to non-exposed controls of the same sex. In
addition, the cadmium-induced changes in DNA methylation
correlated with higher levels of expression ofDNMT3Ameth-
yltransferase in male and lower levels in female rats. The sex-
specific changes in DNA methylation, i.e., hypermethylation
in males and hypomethylation in females, are in line with the
results found in human newborns exposed to much lower
cadmium concentrations [57].
In Vitro Studies
In the only study measuring histone marks, mouse embryonic
stem cells were exposed to cadmium chloride (CdCl2) for 1
and 24 h at concentrations of IC25 and IC50 (extrapolated from
concentration–effect curves; equivalent to a cadmium concen-
tration of 0.08 and 0.16 mM, or 9000 and 16.000 μg/L, re-
spectively) [66]. A significant reduction (more than 50 %) of
global histone lysine monomethylation (H3K27me1), mea-
sured by a fluorimetric assay, was observed in cells after
24 h of exposure at IC50, when compared to non-exposed
cells, and although nonsignificant, a decrease in methylation
of around 20 % was already visible at IC25. The reduction in
histone methylation due to cadmium was similar to that ob-
served for equivalently high concentrations of arsenic, mercu-
ry, and nickel in the same study. Since H3K27me1 is linked to
activation of transcription, these results suggest that cadmium
could trigger transcriptional repression. The effect of long-
term and relatively low-dose exposure to cadmium on global
DNA methylation was analyzed in human embryo lung fibro-
blasts by measuring the total content of methylated cytosine
using reversed-phase high-pressure liquid chromatography
[67]. A significant dose-dependent increase of 26.9 and
31.4 % in global methylation was observed in cells exposed
for 2 months to cadmium at concentrations of 1.2 and
1.5 μmol/L (135 and 169 μg/L), respectively, when compared
to controls. This hypermethylation was accompanied by an
upregulation in the expression of DNA methyltransferases
DNMT1, DNMT3A, and DNMT3B, together with an increase
in cell growth. Finally, acute cadmium exposure in cultured
human choriocarcinoma cells (JEG-3), i.e., cells derived from
a trophoblastic cell carcinoma, was shown to affect expression
of the 11b-hydroxysteroid dehydrogenase type 2 enzyme
(11b-HSD2; encoded by HSD11B2), which is one of the most
important regulators of levels of glucocorticoid in placental
tissue [68]. Cadmium exposure at a dose of 1 μM
(112 μg/L) for 24 h was associated with a significantly higher
HSD11B2 expression, a concomitant (although nonsignifi-
cant) reduction in the promoter DNA methylation of
HSD11B2measured by methylation-specific PCR, and a low-
er cortisol production [69]. This is in contrast to the results of
Yang et al. [31], showing a concentration-dependent decrease
in expression of HSD11B2 with a maximal effect at 0.75 μM
(84 μg/L), accompanied by higher levels of cortisone in nor-
mal trophoblast cells exposed to cadmium in the same condi-
tions. Here, no measures of DNA methylation were conduct-
ed. However, caution should be taken in comparing the results
of the two studies on cadmium andHSD11B2, since the JEG-3
choriocarcinoma cells are tumoral in origin and may behave
differently than normal trophoblasts in their epigenetic
regulation.
Discussion and Conclusions
The body of literature regarding prenatal exposure to cadmi-
um and epigenetic alterations was found to be scarce. How-
ever, all the existing studies ranging from low to very high
doses of exposure reported epigenetic changes in relation to
cadmium, pointing towards epigenetic dysregulation as a
mechanism for early life cadmium toxicity. In particular, as-
sociations of cadmium with DNA methylation of certain CpG
sites within genes of interest in organ development, glucocor-
ticoid synthesis, and cell death have been reported. It remains
to be shown whether the interference of cadmium with epige-
netic processes occurs by direct action in the embryo or fetus
or indirectly via effects on the placenta.Whatever mechanism,
this may result in aberrant gene expression in different tissues
of the developing child, which could explain the various ad-
verse outcomes associated with prenatal cadmium exposure,
i.e., impaired growth, immune toxicity, and endocrine
disruption.
Two studies, one on low-dose exposed women and the
other on extremely highly dosed rats, reported that cadmium
exposure in pregnancy alters fetal DNA methylation in a
marked sex-specific manner [57, 65], which may help clarify
previous findings of differences in toxicity of cadmium ob-
served between girls and boys [14, 15••, 16]. Sex-specific
epigenetic changes have been reported in relation to other
environmental pollutants as well, such as arsenic and endo-
crine disrupting chemicals [47, 70, 71], and stresses the need
to evaluate the influence of sex in future toxicoepigenomic
studies.
A further aspect important to consider for these studies and
their comparison is that cadmium-related epigenetic effects
might differ upon low (environmentally relevant) and high
(likely toxic) doses of exposure. Although epigenetic effects
might only arise upon reaching a certain concentration, as it
has been reported in relation to cadmium and gene expression
[31, 69], a major problem with several of the experimental
studies is the very high doses used, which might not be appli-
cable to cadmium exposure in human populations. This is an
important consideration, especially if epigenetic data in the
future should be incorporated in risk assessment processes
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for toxic metals, as discussed in detail by Ray and coworkers
[36].
Cadmium-induced changes in levels of DNA methyltrans-
ferases could be one mechanism underlying the epigenetic
alterations caused by cadmium, although the direction of the
effects remains unclear. Three of the studies reviewed in the
present work reported changes both in DNA methylation and
in expression of DNA methyltransferases in relation to prena-
tal cadmium exposure. Two of them, conducted in animals at
very high exposure levels, found a decrease in expression of
de novo DNA methyltransferases (both DNMT3A and
DNMT3B or only DNMT3A) along with DNA hypomethyla-
tion, either global or gene-specific [63, 65]. This is similar to
what was reported in a study in adult women exposed to low
cadmium levels from normal food (median 0.23 μg/L in
urine), where increasing cadmium concentrations were asso-
ciated with LINE-1 hypomethylation and lower DNMT3B ex-
pression in peripheral blood [56]. By contrast, opposite results
were observed in vitro in human lung embryo fibroblasts,
showing higher global DNA methylation and DNMT1,
DNMT3A, and DNMT3B expression at concentrations of
135 and 169 μg/L [67], which was consistent with a previous
study conducted in human prostate epithelial cells reporting
higher methylation and DNMT3B expression after long-term,
i.e., 10 weeks high dose (1124 μg/L) cadmium exposure [72].
These differences in cadmium and DNA methyltransferases
might reflect that cadmium affects these enzymes differently
in whole organisms compared to long-term cultured cells or
result from the high variation in the doses from study to study.
DNA methylation was the most widely studied epigenetic
mark; only one study examined histone modifications and
none examined microRNAs. This is likely due to the covalent
and more stable nature of DNA methylation compared to oth-
er epigenetic signatures [73], together with the availability of
techniques that allow its measurement with relatively high-
throughput and quantitative technologies. Future studies in
this field are recommended to work towards the simultaneous
measurement of several epigenetic marks, since they appear to
interact in the genomic context [74], and also examine newly
described epigenetic signals such as DNAhydroxymethylation,
which is thought to regulate gene expression and prompt DNA
demethylation in early pregnancy [75, 76]. Integrating different
regulatory epigenetic marks will help us gain a better biological
picture of the mechanisms related to cadmium toxicity.
It is key in environmental epigenetic studies to choose
carefully the target tissue that will be studied. This can be
driven by previous knowledge associated either with the ex-
posure, i.e., toxicokinetics and toxicodynamics, with the role
of the tissue or the organ in the context of the phenotype
studied, or ideally a combination of both. Placenta warrants
further attention in human studies of prenatal cadmium ef-
fects, considering its multiple biological functions during fetal
development, and especially because it has been shown to be a
partial barrier to the transfer of cadmium frommaternal to fetal
blood stream [77].
In conclusion, most of the currently available literature sug-
gests that prenatal exposure to both low and extremely high
doses of cadmium is associated with epigenetic effects,
representing a plausible mechanism for cadmium toxicity. Al-
though suggestive, the evidence remains too limited to draw
firm conclusions on the direction of the epigenetic changes and
their direct implication for disease outcomes. In particular, it is
difficult to draw conclusions as to the type and degree of dis-
turbances due to the extremely high doses used in several of the
animal and in vitro studies. More research in this area is war-
ranted; focusing on environmentally relevant doses and also
considering the effects of co-exposure during pregnancy to
multiple common environmental contaminants that affect epi-
geneticmarks. Additionally, human studies should aim at larger
sample sizes and the most significant results validated in inde-
pendent but similar populations, especially in the context of
epigenome-wide association studies where a large number of
CpG sites are evaluated simultaneously [78]. This growing
field of research has potential implications for public health in
terms of prevention, especially if epigenetic changes due to
early life cadmium exposure could be used as predictors of later
disease outcome and modified during postnatal life. Therefore,
it is important that existing cohort studies conduct follow-up
studies, because some of the health effects due to early epige-
netic dysregulation from cadmium exposure may likely not
arise until later in life, i.e., in adolescence or adulthood.
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